Health

Health Law360 provides breaking legal news and analysis on the health care industry. Coverage includes litigation, policy developments, and corporate deals involving health care services companies such as hospitals, health insurers, physicians groups, and medical suppliers.



Sign up for a 7-day FREE trial today!



Latest News in Health

  • August 06, 2026

    Judge OKs $35M Teva Deal In Delayed Generic Inhalers Suit

    A Massachusetts federal judge has approved an antitrust settlement that will see Teva Pharmaceuticals pay $35 million to resolve claims that it schemed to delay generic competition for its QVAR asthma inhalers.

  • August 05, 2026

    Product Liability Cases To Watch: Midyear Report

    Social media companies are headed back to court over allegations that their platforms are designed to hook young people, while OpenAI faces claims that ChatGPT has meted out harmful health advice and helped users plan mass shootings. Here's what's on the radar for product liability for the rest of 2026.

  • August 05, 2026

    Drug Cos. Can't Trim Humana's Price-Fix Claims In Bellwether

    A Pennsylvania federal judge on Tuesday denied a bid by a number of generic drug manufacturers to dismiss two antitrust claims brought by health insurer Humana Inc. from an upcoming bellwether trial in long-running antitrust multidistrict litigation, finding they were brought within the statute of limitations.

  • August 05, 2026

    Kansas Judge Permanently Blocks Abortion Care Restrictions

    A Kansas state court has permanently enjoined a slew of restrictions on abortion care, including requirements that providers disclose patients' reasons for seeking an abortion to the state and inform patients about abortion pill "reversal" treatments the court said were "unlikely to be biologically plausible."

  • August 05, 2026

    Takeda Says Rebates, Subsidies Cut $885M IBS Drug Verdict

    Takeda Pharmaceuticals battled with a class of health plans over whether a Massachusetts federal jury's $885 million antitrust verdict against the drugmaker for conspiring to delay generic competition to anticonstipation drug Amitiza should be reduced by rebates the drugmaker paid and Medicare subsidies that reduced the health plans' costs.

See more Health news

Health

Areas of Coverage

  • AGENCIES
  • U.S. Department of Health and Human Services
  • Centers for Medicare and Medicaid Services
  • State and international health care regulators
  • POLICY & REGULATION
  • Affordable Care Act
  • Health Insurance Portability and Accountability Act
  • Patient’s Bill of Rights
  • Stark Law
  • Consumer protection controls
  • Tax-related issues
  • Health care lobbying
  • State and international health care legislation and regulation
  • ENFORCEMENT
  • Health care fraud investigations
  • Merger reviews
  • LITIGATION
  • Medical malpractice and liability suits
  • Mass torts
  • Health care fraud disputes
  • Insurance coverage suits
  • Reimbursement disputes
  • Whistleblower and anti-corruption compliance suits
  • Antitrust suits
  • Breach of contract suits
  • Labor and employment issues
  • Shareholder disputes
  • Bankruptcy proceedings
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures
  • Health care project finance and real estate deals
  • PROFILES
  • Personnel moves
  • Profiles of health attorneys

Readership

  • Health care lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the health care services industry
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals